why choose us

Clinical Trials Search

Showing 14,670 of 132,656 result(s)
Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment

Status: Completed

Condition: Hepatic Impairment

Interventions: Participants receive mitiperstat orally.

Date: 2023-02-21

Mechanisms of Diuretic Resistance in Heart Failure, Aim 2

Status: Completed

Condition: Heart Failure

Interventions: This study will employ a randomized placebo-controlled, double-blind, double-dummy, crossover design testing combinations placebo;placebo, bendro

Date: 2023-02-21

Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia

Status: NOT_YET_RECRUITING

Condition: Developmental Prosopagnosia

Interventions: Computer-based training using faces targeting face memory

Date: 2023-02-21

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Status: Completed

Condition: Non-Small Cell Lung Cancer

Interventions: Participants will receive one of two doses of divarasib orally (PO), QD on days 1-21 of each 21-day cycle.

Date: 2023-02-21

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

Status: Completed

Condition: Labor Long

Interventions: Low dose oxytocin

Date: 2023-02-21

Digital vs. Speculum Exams for PPROM

Status: Completed

Condition: PPROM

Interventions: Same as arm

Date: 2023-02-21

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Status: Completed

Condition: Prostate Cancer

Interventions: 1000 mg of Abiraterone will be given orally daily plus prednisone 5-10 mg daily

Date: 2023-02-21

Accuracy of Extra-oral Bite-wing Radiography in Detecting Calculus and Crestal Bone Loss

Status: Completed

Condition: Periodontitis

Interventions:

Date: 2023-02-21

FEED-Cystic Fibrosis (FEED-CF)

Status: Completed

Condition: Cystic Fibrosis

Interventions: Consist of <5% kcal from added sugars as recommended by the American Heart Association, and the glycemic index will be 45 or lower (25% lower than

Date: 2023-02-21

Rest to Overcome Loss and Reduce Risk

Status: Completed

Condition: Sleep Disturbance

Interventions: This intervention consists of six, 50-min.
online individual sessions delivered via video conference.
Content was developed by tailoring sta

Date: 2023-02-21